Cognitive deficits in Machado-Joseph disease

Annals of Neurology

Volumn 40, Issue 3, 1996, Pages 421-427

  Maruff, P ^a   Tyler, P ^a   Burt, T ^b   Currie, B ^b   Burns, C ^b   Currie, J ^a,c  

^a FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^b ROYAL DARWIN HOSPITAL   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MACHADO JOSEPH DISEASE; MALE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; VISUAL INFORMATION; VISUAL STIMULATION;

EID: 0029809405     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410400311     Document Type: Article

References (30)

1. Spinella GM, Sheridan PH. Research initiatives on Machado-Joseph disease: National Institute of Neurological Disorders and Stroke workshop summary. Neurology 1992;42:2048-2051
2. Rosenberg RN. Machado-Joseph disease: an autosomal dominant motor system degeneration. Move Disord 1992;7:1993-203
3. Sudarsky L, Coutinho P. Machado-Joseph disease. Clin Neurosci 1995;3:17-22
4. Rosenberg RN. The genetic basis of ataxia. Clin Neurosci 1995;3:1-4
5. Rosenberg RN. Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 1995;45:1-5
6. Genis D, Matilla T, Volpini V, et al. Clinical, neuropathologic and genetic studies of a large spinocerebellar axtaxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology 1995;45:24-30
7. Zoghbi HY. Spinocerebellar ataxia type 1. Clin Neurosci 1995; 3:5-11
8. Kawaguchi Y, Okamoto T, Taniwaki M, et al. CAG gene expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet 1994;8:221-227
9. Sequeiros J, Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. In: Harding A, Deufel T, eds. Inherited ataxias: advances in neurology, vol 61. New York: Raven Press, 1993
10. Harding AE. The hereditary ataxias and related disorders. New York: Churchill Livingstone, 1984
11. Berent S, Giordani B, Gilman S, et al. Neuropsychological changes in olivopontocerebellar atrophy. Arch Neurol 1990; 47:997-1001
12. Lalonde R, Botez T, Botez MI. Methodologic considerations in neuropsychological testing of ataxic patients. Arch Neurol 1992;49:218 (Letter)
13. Kish SJ, El-Awar M, Stuss D, et al. Neuropsychological test performance in patients with dominantly inherited spinocereballar ataxia - relationship to ataxia severity. Neurology 1993; 44:1738-1746
14. Kish SJ, El-Awar M, Schut L, et al. Cognitive deficits in the olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia. Ann Neurol 1988;24: 200-206
15. Sudarsky L, Corwin L, Dawson DM. Machado-Joseph disease in New England: clinical description and distinction from the olivopontocerebellar atrophies. Move Disord 1992;7:204-208
16. Goldberg-Stern H, D'jaldetti R, Melamed E, Gadoth N. Machado-Joseph (Azorean) disease in a Yeminite Jewish family in Israel. Neurology 1994;44:1298-1301
17. Radvany J, Camargo CHP, Costa ZM, et al. Machado-Joseph disease of Azorean ancestory in Brazil: the Catarina kindred. Neurological, neuroimaging, psychiatric and neuropsychological findings in the largest known family, the "Catarina" kindred. Arq Neuropsiquiatr 1993;51:21-30
18. Goldman-Rakic PS. Circuitry of primate prefrontal cortex and regulation of behaviour by representational memory. In: Plum F, Mountcastle V, eds. Higher cortical function. American Physiological Society handbook of physiology, vol 5. Bethesda, MD: American Physiological Society, 1987:373-417
19. Burt T, Blumbergs P, Currier B. A dominant hereditary ataxia resembling Machado-Joseph disease in Arnhem Land, Australia. Neurology 1993;43:1750-1752
20. Burt T, Currie B, Kilburn C, et al. Machado-disease in East Arnhem Land, Australia: chromosome 14q32.1 expanded repeat confirmed in four families. Neurology (In press)
21. Cambridge Neuropsychological Test Automated Battery (CANTAB): a factor analytic study of a large sample of normal elderly volunteers. Dementia 1994;5:266-281
22. Robbins TW, James M, Lange KW, et al. Cognitive performance in multiple system atrophy. Brain 1992;115:271-291
23. Robbins TW, James M, Owen AM, et al. Cognitive deficits in progressive supranuclear palsy, Parkinson's disease, and multiple system atrophy in tests sensitive to frontal lobe dysfunction. J Neurol Neurosurg Psychiatry 1994;57:79-88
24. Owen AM, Roberts AC, Hodges JR, et al. Contrasting mechanisms of impaired set shifting in patients with frontal lobe damage or Parkinson's disease. Brain 1993;116:1159-1175
25. Owen AW, James M, Leigh PN, et al. Fronto-striatal cognitive deficits at different stages of Parkinson's disease. Brain 1992; 115:1727-1751
26. Sahakian BJ, Owen AM, Morant NJ, et al. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB. Psychopharmacology 1993;110: 395-401
27. Owen AM, Bekinska M, James M, et al. Visuospatial memory deficits at different stages of Parkinson's disease. Neuropsychologia 1993;31:627-644
28. Owen AM, Roberts AC, Polkey CE, et al. Extradimensional versus intradimensional set shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalahippocampectomy in man. Neuropsychologia 1991;29:993-1006
29. Sahakian BJ, Morris RG, Evenden JL, et al. A comparative study of visuospatial memory and learning in Alzheimer's disease and Parkinson's disease. Brain 1988;111:695-718
30. Owen AM, Sahakian BJ, Semple J, et al. Visuo-spatial short-term recognition memory and learning after temporal lobe excisions, frontal lobe excisions or amygdalo-hippocampectomy in man. Neuropsychologia 1995;33:1-24